Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics

We’re pleased to report that we’ve further strengthened our team in Oxford.

It’s a busy time for Samsara Therapeutics as we move into our new purpose-built labs and offices in the Wood Centre for Innovation in Oxford.

Samsara Therapeutics Receives $3.2 Million Seed Funding for Further Pipeline Expansion.